Filing Details
- Accession Number:
- 0001104659-20-035492
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-18 18:00:53
- Reporting Period:
- 2020-03-17
- Accepted Time:
- 2020-03-18 18:00:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1481512 | Ra Pharmaceuticals Inc. | RARX | Pharmaceutical Preparations (2834) | 262908274 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1768722 | Alonso Ricardo | C/O Ra Pharmaceuticals, Inc. 87 Cambridgepark Drive Cambridge MA 02140 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-03-17 | 2,288 | $44.25 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2019.